If you want to monitor your vital signs like an Olympic athlete, you should welcome a pact between glucose-monitor vendor DexCom and Oura smart rings.

Smart ring company Oura announced it received $75 million in funding from glucose monitoring and diagnostics company Dexcom. The strategic investment brings Oura’s valuation to more than $5 billion and allows the companies to begin integrating data between Dexcom’s continuous glucose monitoring products and Oura’s smart ring and application.

Dexcom has invested $75 million into Oura, which values Oura at $5 billion. And the details of the deal could have a significant impact.